CRH Medical Corporation Common Shares of Beneficial Interest (CRHM): Price and Financial Metrics


CRH Medical Corporation Common Shares of Beneficial Interest (CRHM)

Today's Latest Price: $2.20 USD

0.01 (-0.45%)

Updated Oct 23 8:00pm

Add CRHM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

CRHM Stock Summary

  • CRHM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.2 -- higher than merely 4.26% of US-listed equities with positive expected earnings growth.
  • Of note is the ratio of CRH Medical Corp's sales and general administrative expense to its total operating expenses; 87.82% of US stocks have a lower such ratio.
  • For CRHM, its debt to operating expenses ratio is greater than that reported by 88.9% of US equities we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CRH Medical Corp are AQMS, CHCI, FN, OGI, and DHIL.
  • CRHM's SEC filings can be seen here. And to visit CRH Medical Corp's official web site, go to investors.crhsystem.com.

CRHM Stock Price Chart Interactive Chart >

Price chart for CRHM

CRHM Price/Volume Stats

Current price $2.20 52-week high $4.43
Prev. close $2.21 52-week low $0.86
Day low $2.18 Volume 46,156
Day high $2.22 Avg. volume 107,930
50-day MA $2.30 Dividend yield N/A
200-day MA $2.47 Market Cap 157.30M

CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Company Bio


CRH Medical Corporation, a medical company, provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company was founded in 2000 and is based in Vancouver, Canada.

CRHM Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$2.20$7.9 254%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for CRH Medical Corp. To summarize, we found that CRH Medical Corp ranked in the 72th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for CRH Medical Corp ended up being:

  • CRH Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 72.61% of tickers in our DCF set.
  • CRHM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 13%; for context, that number is higher than 72.61% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), CRH Medical Corp has a reliance on debt greater than 68.63% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%247%
1%251%
2%254%
3%258%
4%261%
5%265%

HUM, UHS, NVO, SKVI, and DVA can be thought of as valuation peers to CRHM, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


CRHM Latest News Stream


Event/Time News Detail
Loading, please wait...

CRHM Latest Social Stream


Loading social stream, please wait...

View Full CRHM Social Stream

Latest CRHM News From Around the Web

Below are the latest news stories about CRH Medical Corp that investors may wish to consider to help them evaluate CRHM as an investment opportunity.

CRH Medical Corporation: Needing Their Service And Owning Their Stock Might Make You Forget The 'Prep'

(The title for my article will only have meaning for those who have had a colonoscopy - I've had three! But never ignore having such a procedure!) When the stock market, in March, crashed by more than 30% due the full impact of COVID-19 becoming known, I began my due...

Looking For Diogenes on Seeking Alpha | August 18, 2020

CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q2 2020 Results - Earnings Call Transcript

CRH Medical Corporation (CRHM) Q2 2020 Earnings Conference Call August 11, 2020 8:30 A.M. ET Company Participants Richard Bear - Chief Financial Officer Tushar Ramani - Chief Executive Office Jay Kreger - President of CRH Anesthesia Tom Sanders - Vice President of Commercial Development Conference Call Participants Richard Close -...

SA Transcripts on Seeking Alpha | August 11, 2020

CRH Medical Corporation to Announce 2020 Second Quarter Results on August 10, 2020

VANCOUVER, BC, Aug. 3, 2020 /CNW/ - CRH Medical Corporation (TSX:CRH) (NYSE:CRHM) ("CRH" or the "Company"), plans to release its results for …

Benzinga | August 3, 2020

Here's What CRH Medical Corporation's (TSE:CRH) Shareholder Ownership Structure Looks Like

Every investor in CRH Medical Corporation (TSE:CRH) should be aware of the most powerful shareholder groups. Generally...

Yahoo | July 15, 2020

CRH Medical Corporation Announces Majority Purchase of Central Virginia Anesthesia Associates

CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that it has completed an accretive transaction whereby the Company has acquired a 51% interest in Central Virginia Anesthesia Associates, LLC ("Central Virginia"), a gastroenterology ("GI") anesthesia practice located in Virginia.

Yahoo | July 7, 2020

Read More 'CRHM' Stories Here

CRHM Price Returns

1-mo 3.77%
3-mo -1.35%
6-mo 4.27%
1-year -26.67%
3-year -8.33%
5-year -31.25%
YTD -36.60%
2019 13.77%
2018 15.09%
2017 -49.52%
2016 77.97%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8695 seconds.